001400049 000__ 02783nam\a2200469\a\4500
001400049 001__ 1400049
001400049 003__ MiAaPQ
001400049 005__ 20220701003148.0
001400049 006__ m\\\\\o\\d\\\\\\\\
001400049 007__ cr\cn\nnnunnun
001400049 008__ 130314s2014\\\\flua\\\\ob\\\\001\0\eng\d
001400049 010__ $$z  2013010316
001400049 020__ $$z9781466587144 (hardback : alk. paper)
001400049 020__ $$z9781466587151 (e-book)
001400049 035__ $$a(MiAaPQ)EBC1335842
001400049 035__ $$a(Au-PeEL)EBL1335842
001400049 035__ $$a(CaPaEBR)ebr10735260
001400049 035__ $$a(CaONFJC)MIL518693
001400049 035__ $$a(OCoLC)855504706
001400049 040__ $$aMiAaPQ$$cMiAaPQ$$dMiAaPQ
001400049 050_4 $$aRC670$$b.B56 2014
001400049 08204 $$a616.1/075$$223
001400049 24500 $$aBiomarkers in cardiovascular diseases /$$ceditors, Dimitris Tousoulis, Christodoulos Stefanadis.
001400049 260__ $$aBoca Raton :$$bCRC Press,$$c2014.
001400049 300__ $$a1 online resource (viii, 439 pages ) :$$billustrations
001400049 336__ $$atext$$2rdacontent
001400049 337__ $$acomputer$$2rdamedia
001400049 338__ $$aonline resource$$2rdacarrier
001400049 504__ $$aIncludes bibliographical references and index.
001400049 5050_ $$apt. 1. Classical biomarkers -- pt. 2. Novel biomarkers.
001400049 506__ $$aAccess limited to authorized users.
001400049 520__ $$a"The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book"--Provided by publisher.
001400049 650_0 $$aCardiovascular system$$xDiseases$$xDiagnosis.
001400049 650_0 $$aCardiovascular system$$xDiseases$$xPrevention.
001400049 655_0 $$aElectronic books
001400049 7001_ $$aTousoulis, Dimitris.
001400049 7001_ $$aStefanadis, Christodoulos.
001400049 852__ $$bebk
001400049 85640 $$3ProQuest Ebook Central Academic Complete $$uhttps://univsouthin.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/usiricelib-ebooks/detail.action?docID=1335842$$zOnline Access
001400049 909CO $$ooai:library.usi.edu:1400049$$pGLOBAL_SET
001400049 980__ $$aBIB
001400049 980__ $$aEBOOK
001400049 982__ $$aEbook
001400049 983__ $$aOnline